Bargersville, IN, United States of America

Winston S Marshall

This inventor holds 37 USPTO granted patents, primarily in Leukotriene Antagonists. Top assignees: Eli Lilly and Company, Lilly Industries, Inc.. Active years: 1976-1998.


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 233(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1976 - 1979)
  • Bargerville, IN (US) (1996)
  • Bargersville, IN (US) (1976 - 1997)
  • Hermosa Beach, CA (US) (1998)

Company Filing History:


Years Active: 1976-1998

Loading Chart...
Areas of Expertise:
Leukotriene Antagonists
Angiotensin II Antagonists
Anti-Inflammatory Agents
Pharmaceutical Compositions
Decahydroisoquinolines
Tetrazole Compounds
Arylacetylene Compounds
Antithrombotic Agents
Quinoxalinedione
Benzonitrile Intermediates
Cyano Intermediates
Halogenated Compounds
37 patents (USPTO):Explore Patents

Title: Winston S. Marshall: Innovator in Pharmacology

Introduction

Winston S. Marshall, based in Bargersville, Indiana, has established himself as a significant contributor to the field of pharmacology with a remarkable portfolio of 36 patents. His work has made considerable advances in understanding and treating physiological conditions, particularly through his innovative compounds targeting angiotensin II receptors.

Latest Patents

Among his latest patents, Winston has developed angiotensin II antagonists that provide novel heterocyclic derivatives. These inventions include pharmaceutical formulations aimed at antagonizing angiotensin II receptors in mammals, showcasing his commitment to advancing therapeutic treatments in modern medicine.

Career Highlights

Winston's career includes pivotal roles at renowned companies such as Eli Lilly and Company and Lilly Industries, Inc. His efforts within these organizations have been instrumental in translating innovative concepts into practical applications that enhance patient care and treatment options.

Collaborations

Throughout his career, Winston has worked alongside notable colleagues, including Celia A. Whitesitt and Sherryl L. Lifer. These collaborations have facilitated the sharing of expertise and have contributed to the successful development of numerous pharmaceutical strategies and solutions.

Conclusion

Winston S. Marshall's contributions to pharmacology through his numerous patents and collaborative efforts with esteemed colleagues reflect his dedication to innovation and improvement in medical therapies. His work continues to inspire future research and development within the industry, paving the way for new breakthroughs in the treatment of various conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…